Gardner Lewis Asset Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Gardner Lewis Asset Management’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-44,340	Closed	-$7.66M	–	125
2015 Q1	$7.66M	Buy	+44,340	New	+$6.51M	1.61%	16

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Gardner Lewis Asset Management's SLXP Position: Q2 2015 in Review

Gardner Lewis Asset Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 44,340 shares — an estimated $7.66M sold.

Gardner Lewis Asset Management first reported a position in SLXP in Q1 2015 and held it in 1 quarter. The position peaked at $7.66M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Gardner Lewis Asset Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Gardner Lewis Asset Management sold 44,340 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $7.66M.
Gardner Lewis Asset Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q1 2015 and held it in 1 quarter.
Gardner Lewis Asset Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $7.66M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Gardner Lewis Asset Management's 13F filing for Q2 2015, filed 13 Aug 2015.